Chinese biopharma stocks jumped in Hong Kong after a Reuters report said the U.S. is drafting rules that could let American drugmakers keep licensing most drugs from Chinese firms, with exclusions for certain pathogens and weaponizable biotech.
What's Your Reaction?
Like
0
Dislike
0
Love
0
Funny
0
Angry
0
Sad
0
Wow
0
